DDInter779 DDInter1763
An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpes viruses and HIV.
Temsirolimus is a derivative of sirolimus used in the treatment of renal cell carcinoma (RCC). It was developed by Wyeth Pharmaceuticals under the trade name Torisel. Temsirolimus was approved by the FDA in late May 2007 as well as the European Medicines Agency (EMEA) on November 2007.
Foscarnet {u} may lead to a major life threatening interaction when taken with {v} Sirolimus
Sirolimus {u} (Compound) resembles {v} (Compound) Temsirolimus
Foscarnet {u} (Compound) causes {v} (Side Effect) Pharyngitis
Pharyngitis {u} (Side Effect) is caused by {v} (Compound) Temsirolimus
Foscarnet {u} may lead to a major life threatening interaction when taken with {v} Sirolimus
Sirolimus {u} (Compound) resembles {v} (Compound) Everolimus
Everolimus {u} (Compound) resembles {v} (Compound) Temsirolimus
Foscarnet {u} (Compound) causes {v} (Side Effect) Pharyngitis
Pharyngitis {u} (Side Effect) is caused by {v} (Compound) Everolimus
Everolimus {u} (Compound) resembles {v} (Compound) Temsirolimus
Foscarnet {u} (Compound) binds {v} (Gene) SLC22A6
SLC22A6 {u} (Gene) covaries with {v} (Gene) HMOX1
HMOX1 {u} (Gene) is upregulated by {v} (Compound) Temsirolimus
Foscarnet {u} (Compound) binds {v} (Gene) SLC16A1
SLC16A1 {u} (Gene) regulates {v} (Gene) CASP10
CASP10 {u} (Gene) is upregulated by {v} (Compound) Temsirolimus
Foscarnet {u} may lead to a major life threatening interaction when taken with {v} Sirolimus
Sirolimus {u} (Compound) binds {v} (Gene) CYP3A4
CYP3A4 {u} (Gene) is bound by {v} (Compound) Temsirolimus
Foscarnet {u} (Compound) binds {v} (Gene) SLC16A1
SLC16A1 {u} (Gene) is regulated by {v} (Gene) MOK
MOK {u} (Gene) is upregulated by {v} (Compound) Temsirolimus
Foscarnet {u} (Compound) binds {v} (Gene) SLC16A1
SLC16A1 {u} (Gene) regulates {v} (Gene) PPP2R3C
PPP2R3C {u} (Gene) is downregulated by {v} (Compound) Temsirolimus
Foscarnet {u} may lead to a major life threatening interaction when taken with {v} Sirolimus
Sirolimus {u} (Compound) upregulates {v} (Gene) KIAA0355
KIAA0355 {u} (Gene) is upregulated by {v} (Compound) Temsirolimus
Foscarnet may lead to a major life threatening interaction when taken with Sirolimus and Sirolimus (Compound) resembles Temsirolimus (Compound)
Foscarnet (Compound) causes Pharyngitis (Side Effect) and Pharyngitis (Side Effect) is caused by Temsirolimus (Compound)
Foscarnet may lead to a major life threatening interaction when taken with Sirolimus and Sirolimus (Compound) resembles Everolimus (Compound) and Everolimus (Compound) resembles Temsirolimus (Compound)
Foscarnet (Compound) causes Pharyngitis (Side Effect) and Pharyngitis (Side Effect) is caused by Everolimus (Compound) and Everolimus (Compound) resembles Temsirolimus (Compound)
Foscarnet (Compound) binds SLC22A6 (Gene) and SLC22A6 (Gene) covaries with HMOX1 (Gene) and HMOX1 (Gene) is upregulated by Temsirolimus (Compound)
Foscarnet (Compound) binds SLC16A1 (Gene) and SLC16A1 (Gene) regulates CASP10 (Gene) and CASP10 (Gene) is upregulated by Temsirolimus (Compound)
Foscarnet may lead to a major life threatening interaction when taken with Sirolimus and Sirolimus (Compound) binds CYP3A4 (Gene) and CYP3A4 (Gene) is bound by Temsirolimus (Compound)
Foscarnet (Compound) binds SLC16A1 (Gene) and SLC16A1 (Gene) is regulated by MOK (Gene) and MOK (Gene) is upregulated by Temsirolimus (Compound)
Foscarnet (Compound) binds SLC16A1 (Gene) and SLC16A1 (Gene) regulates PPP2R3C (Gene) and PPP2R3C (Gene) is downregulated by Temsirolimus (Compound)
Foscarnet may lead to a major life threatening interaction when taken with Sirolimus and Sirolimus (Compound) upregulates KIAA0355 (Gene) and KIAA0355 (Gene) is upregulated by Temsirolimus (Compound)